NR 568 FINAL EXAM QUESTIONS
]] ]
& CORRECT ANSWERS Latest Update -
& ] ] ] ]
2026-2027
Prevention ]of ]Osteoporosis ]with ]Hormone ]Replacement ]Therapy ]- ]correct ]answer: ]Estrogen ]ther
apy ]helps ]maintain ]bone ]density ]and ]prevent ]osteoporosis ]in ]postmenopausal ]women. ]HRT ]is ]o
nly ]recommended ]when ]the ]benefits ]outweigh ]risks
When/when ]not ]to ]use ]progestin ]for ]HRT ]- ]correct ]answer: ]Should ]be ]added ]to ]estrogen ]therapy
]in ]women ]with ]an ]intact ]uterus ]to ]prevent ]endometrial ]hyperplasia ]and ]reduce ]risk ]of ]endomet
rial ]cancer. ]UNNECESSARY ]IN ]WOMEN ]WITHOUT ]A ]UTERUS
What ]are ]local ]estrogen ]options ]and ]what ]are ]they ]used ]for ]- ]correct ]answer: ]ex: ]vaginal ]rings ]an
d ]creams, ]used ]for ]GU ]symptoms ]like ]vaginal ]dryness ]without ]significant ]systemic ]effects
What ]are ]system ]estrogen ]options ]and ]what ]are ]they ]used ]for ]- ]correct ]answer: ]ex: ]transdermal ]
patches ]and ]oral ]formulations, ]used ]for ]generalized ]menopausal ]symptoms ]such ]as ]hot ]flashes ]a
nd ]prevention ]of ]osteoporosis
What ]are ]transdermal ]estrogen ]options ]and ]what ]are ]they ]used ]for ]- ]correct ]answer: ]has ]fewer ]
adverse ]effects ]compared ]to ]oral ]estrogen ]and ]has ]a ]reduced ]risk ]of ]venous ]thromboembolism ]a
nd ]stroke
What ]Selective ]Estrogen ]Receptor ]Modulator ]
(SERM) ]is ]used ]to ]treat ]osteoporosis ]- ]correct ]answer: ]Bazedoxifene, ]benefits ]bones ]and ]protect
s ]against ]breast ]cancer
, How ]do ]you ]change ]a ]patient ]from ]one ]combo ]oral ]contraceptive ]
(OC) ]to ]another ]- ]correct ]answer: ]Switch ]after ]the ]last ]active ]pill ]of ]the ]previous ]pack ]without ]a ]
break
How ]to ]start ]OC ]treatment ]- ]correct ]answer: ]best ]to ]start ]on ]the ]first ]day ]of ]menstruations ]or ]th
e ]first ]Sunday ]after ]menstruations. ]If ]started ]mid-
cycle, ]backup ]contraption ]should ]be ]used ]for ]a ]week
What ]to ]educate ]patients ]on ]when ]taking ]OCs ]- ]correct ]answer: ]Importance ]of ]adherence, ]what ]
to ]do ]if ]dose ]is ]missed, ]and ]potential ]side ]effects ]ex: ]nausea, ]breakthrough ]bleeding
What ]baseline ]data ]is ]need ]to ]start ]OCs ]- ]correct ]answer: ]blood ]pressure ]and ]thorough ]medical ]
history ]to ]assess ]for ]contraindications ]ex: ]hx ]of ]thromboembolic ]disease
How ]to ]suggest ]the ]appropriate ]birth ]control ]method ]- ]correct ]answer: ]Consider ]the ]patients ]he
alth ]status, ]risk ]of ]thromboembolism, ]preference ]for ]daily ]vs ]long ]term ]contraception
What ]effect ]do ]CYP450 ]inhibitors ]have ]on ]OCs ]- ]correct ]answer: ]ex: ]grapefruit ]juice ]and ]erythro
mycin. ]Increase ]the ]level ]of ]estrogen ]which ]increases ]the ]risk ]of ]adverse ]effects
What ]effect ]do ]CYP450 ]inducers ]have ]on ]OCs ]- ]correct ]answer: ]ex: ]rifampin ]and ]phenytoin. ]Redu
ces ]the ]effectiveness ]of ]OCs ]which ]increase ]the ]risk ]for ]pregnancy. ]Use ]a ]backup
benefits ]of ]progestin ]only ]contraceptives ]- ]correct ]answer: ]safe ]for ]women ]who ]are ]breastfeedin
g ]or ]at ]risk ]for ]estrogen ]related ]complications ](thromboembolism)
Drawbacks ]of ]Progestin-
only ]contraception ]- ]correct ]answer: ]must ]be ]taken ]at ]the ]same ]time ]each ]day ]with ]strict ]adhere
nce, ]higher ]incidence ]of ]breakthrough ]bleeding
]] ]
& CORRECT ANSWERS Latest Update -
& ] ] ] ]
2026-2027
Prevention ]of ]Osteoporosis ]with ]Hormone ]Replacement ]Therapy ]- ]correct ]answer: ]Estrogen ]ther
apy ]helps ]maintain ]bone ]density ]and ]prevent ]osteoporosis ]in ]postmenopausal ]women. ]HRT ]is ]o
nly ]recommended ]when ]the ]benefits ]outweigh ]risks
When/when ]not ]to ]use ]progestin ]for ]HRT ]- ]correct ]answer: ]Should ]be ]added ]to ]estrogen ]therapy
]in ]women ]with ]an ]intact ]uterus ]to ]prevent ]endometrial ]hyperplasia ]and ]reduce ]risk ]of ]endomet
rial ]cancer. ]UNNECESSARY ]IN ]WOMEN ]WITHOUT ]A ]UTERUS
What ]are ]local ]estrogen ]options ]and ]what ]are ]they ]used ]for ]- ]correct ]answer: ]ex: ]vaginal ]rings ]an
d ]creams, ]used ]for ]GU ]symptoms ]like ]vaginal ]dryness ]without ]significant ]systemic ]effects
What ]are ]system ]estrogen ]options ]and ]what ]are ]they ]used ]for ]- ]correct ]answer: ]ex: ]transdermal ]
patches ]and ]oral ]formulations, ]used ]for ]generalized ]menopausal ]symptoms ]such ]as ]hot ]flashes ]a
nd ]prevention ]of ]osteoporosis
What ]are ]transdermal ]estrogen ]options ]and ]what ]are ]they ]used ]for ]- ]correct ]answer: ]has ]fewer ]
adverse ]effects ]compared ]to ]oral ]estrogen ]and ]has ]a ]reduced ]risk ]of ]venous ]thromboembolism ]a
nd ]stroke
What ]Selective ]Estrogen ]Receptor ]Modulator ]
(SERM) ]is ]used ]to ]treat ]osteoporosis ]- ]correct ]answer: ]Bazedoxifene, ]benefits ]bones ]and ]protect
s ]against ]breast ]cancer
, How ]do ]you ]change ]a ]patient ]from ]one ]combo ]oral ]contraceptive ]
(OC) ]to ]another ]- ]correct ]answer: ]Switch ]after ]the ]last ]active ]pill ]of ]the ]previous ]pack ]without ]a ]
break
How ]to ]start ]OC ]treatment ]- ]correct ]answer: ]best ]to ]start ]on ]the ]first ]day ]of ]menstruations ]or ]th
e ]first ]Sunday ]after ]menstruations. ]If ]started ]mid-
cycle, ]backup ]contraption ]should ]be ]used ]for ]a ]week
What ]to ]educate ]patients ]on ]when ]taking ]OCs ]- ]correct ]answer: ]Importance ]of ]adherence, ]what ]
to ]do ]if ]dose ]is ]missed, ]and ]potential ]side ]effects ]ex: ]nausea, ]breakthrough ]bleeding
What ]baseline ]data ]is ]need ]to ]start ]OCs ]- ]correct ]answer: ]blood ]pressure ]and ]thorough ]medical ]
history ]to ]assess ]for ]contraindications ]ex: ]hx ]of ]thromboembolic ]disease
How ]to ]suggest ]the ]appropriate ]birth ]control ]method ]- ]correct ]answer: ]Consider ]the ]patients ]he
alth ]status, ]risk ]of ]thromboembolism, ]preference ]for ]daily ]vs ]long ]term ]contraception
What ]effect ]do ]CYP450 ]inhibitors ]have ]on ]OCs ]- ]correct ]answer: ]ex: ]grapefruit ]juice ]and ]erythro
mycin. ]Increase ]the ]level ]of ]estrogen ]which ]increases ]the ]risk ]of ]adverse ]effects
What ]effect ]do ]CYP450 ]inducers ]have ]on ]OCs ]- ]correct ]answer: ]ex: ]rifampin ]and ]phenytoin. ]Redu
ces ]the ]effectiveness ]of ]OCs ]which ]increase ]the ]risk ]for ]pregnancy. ]Use ]a ]backup
benefits ]of ]progestin ]only ]contraceptives ]- ]correct ]answer: ]safe ]for ]women ]who ]are ]breastfeedin
g ]or ]at ]risk ]for ]estrogen ]related ]complications ](thromboembolism)
Drawbacks ]of ]Progestin-
only ]contraception ]- ]correct ]answer: ]must ]be ]taken ]at ]the ]same ]time ]each ]day ]with ]strict ]adhere
nce, ]higher ]incidence ]of ]breakthrough ]bleeding
